A Phase 2 interventional study of Dexpanthenol foam spray, new formulation and Dexpanthenol foam spray, old formulation in Skin Abnormalities, sponsored by Bayer. Completed at 1 site in France. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-10-15.
Sponsored by Bayer · Phase 2, Interventional, and Treatment
The study focuses to prove the equivalent moisturizing effect of two different Dexpanthenol formulations
39 studies on the registry are indexed under Skin Abnormalities; 7 are open to participants now.
This study's enrollment of 19 is below the median of 39 across 26 interventional studies indexed under Skin Abnormalities.
Browse Skin Abnormalities studies →Bayer is the lead sponsor of 1,674 studies on the registry; 51 are open to participants now.
Of its 214 completed or terminated interventional studies of FDA-regulated products, 132 (62%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: Dexpanthenol foam spray, new formulation
Drug: Dexpanthenol foam spray, old formulation
2 applications of 2 micro liter/square centimeter on a 4X4 cm area corresponding to 32 micro liter
2 applications of 2 micro liter/square centimeter on a 4X4 cm area corresponding to 32 micro liter
Area Under Curve (AUC) of the cutaneous hydration rate measured with corneometer between T0 and T5h
Time frame: 0 min, 15 min, 30 min, 1h, 2h, 3h, 5h
Cutaneous hydration rate
Time frame: 15 min, 30 min, 1h, 2h, 3h, 5h
Incidence of Adverse Events
Time frame: FPFV - LPLV
The record gives a start of Aug 2007, a primary completion of Sep 2007 and a completion of Sep 2007. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.